Order Article Reprints

Koni M, Castellano I, Venturelli E, Sarcinella A, Lopatina T, Grange C, Cedrino M, Femminò S, Cossu-Rocca P, Orrù S, et al. Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target. Cancers. 2022; 14(16):3918. https://doi.org/10.3390/cancers14163918

Koni, Malvina, Isabella Castellano, Emilio Venturelli, Alessandro Sarcinella, Tatiana Lopatina, Cristina Grange, Massimo Cedrino, Saveria Femminò, Paolo Cossu-Rocca, Sandra Orrù, and et al. 2022. "Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target" Cancers 14, no. 16: 3918. https://doi.org/10.3390/cancers14163918

Koni, M., Castellano, I., Venturelli, E., Sarcinella, A., Lopatina, T., Grange, C., Cedrino, M., Femminò, S., Cossu-Rocca, P., Orrù, S., D’Ascenzo, F., Cotellessa, I., Tampieri, C., Debernardi, C., Cugliari, G., Matullo, G., Camussi, G., De Miglio, M. R., & Brizzi, M. F. (2022). Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target. Cancers, 14(16), 3918. https://doi.org/10.3390/cancers14163918